[
    [
        {
            "time": "",
            "orginal_text": "深度丨云南白药压力测试：炒股浮亏和激励费用‘透支’业绩",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股浮亏",
                    "激励费用",
                    "业绩透支"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "深度丨云南白药压力测试：炒股浮亏和激励费用‘透支’业绩",
            "scores": {
                "News_content": "深度丨云南白药压力测试：炒股浮亏和激励费用‘透支’业绩",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "人民金融·创新药指数涨1.24% | 16款在研，7款步入三期临床，HPV疫苗一针难求待解",
            "features": {
                "keywords": [
                    "创新药指数",
                    "HPV疫苗",
                    "三期临床"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "人民金融·创新药指数涨1.24% | 16款在研，7款步入三期临床，HPV疫苗一针难求待解",
            "scores": {
                "News_content": "人民金融·创新药指数涨1.24% | 16款在研，7款步入三期临床，HPV疫苗一针难求待解",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "炒股‘炒’上热搜的云南白药回应了！",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股",
                    "回应"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "炒股‘炒’上热搜的云南白药回应了！",
            "scores": {
                "News_content": "炒股‘炒’上热搜的云南白药回应了！",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "你为什么吃不起药了？国发股份一年研发费仅5万块 营销费却花了3000万",
            "features": {
                "keywords": [
                    "国发股份",
                    "研发费",
                    "营销费"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "你为什么吃不起药了？国发股份一年研发费仅5万块 营销费却花了3000万",
            "scores": {
                "News_content": "你为什么吃不起药了？国发股份一年研发费仅5万块 营销费却花了3000万",
                "Correlation": 7,
                "Sentiment": 2,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "这家药企‘太不务正业’！迷恋股市投资，前三季共亏15亿！公司：会逐步退出证券投资！",
            "features": {
                "keywords": [
                    "药企",
                    "股市投资",
                    "亏损",
                    "退出投资"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "这家药企‘太不务正业’！迷恋股市投资，前三季共亏15亿！公司：会逐步退出证券投资！",
            "scores": {
                "News_content": "这家药企‘太不务正业’！迷恋股市投资，前三季共亏15亿！公司：会逐步退出证券投资！",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "恒瑞医药现2笔大宗交易 共成交52,030.00万元",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "大宗交易"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "恒瑞医药现2笔大宗交易 共成交52,030.00万元",
            "scores": {
                "News_content": "恒瑞医药现2笔大宗交易 共成交52,030.00万元",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "北向资金逆势加仓超71亿，贵州茅台获大幅净买入13亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "加仓",
                    "贵州茅台"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "北向资金逆势加仓超71亿，贵州茅台获大幅净买入13亿元",
            "scores": {
                "News_content": "北向资金逆势加仓超71亿，贵州茅台获大幅净买入13亿元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "恒瑞医药：SHR0410注射液获药物临床试验批准通知书",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "SHR0410",
                    "临床试验"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "恒瑞医药：SHR0410注射液获药物临床试验批准通知书",
            "scores": {
                "News_content": "恒瑞医药：SHR0410注射液获药物临床试验批准通知书",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "中1签亏1万3、煤炭股重挫8%、外资加仓57亿",
            "features": {
                "keywords": [
                    "煤炭股",
                    "外资加仓"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "煤炭",
                    "外资"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "中1签亏1万3、煤炭股重挫8%、外资加仓57亿",
            "scores": {
                "News_content": "中1签亏1万3、煤炭股重挫8%、外资加仓57亿",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 6,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "云南白药炒股亏15亿，市值已蒸发900亿 网友：现实版《突围》？ 投资失误",
            "features": {
                "keywords": [
                    "云南白药",
                    "炒股亏",
                    "市值蒸发",
                    "投资失误"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "云南白药炒股亏15亿，市值已蒸发900亿 网友：现实版《突围》？ 投资失误",
            "scores": {
                "News_content": "云南白药炒股亏15亿，市值已蒸发900亿 网友：现实版《突围》？ 投资失误",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]